Navigation Links
SCH 530348 (TRA), a Novel Investigational Antiplatelet Agent, Shown to Inhibit Platelet Aggregation in PCI Patients
Date:11/7/2007

romising therapeutic option for patients with unstable angina and non-ST elevation MI undergoing PCI ," said Rick Veltri, M.D., Group Vice President of Global Clinical Research, Cardiovascular and Metabolic Disease, Schering- Plough Research Institute. "With our global Phase III clinical development program underway, we are continuing to evaluate the potential for TRA as a novel agent in reducing the incidence of cardiovascular events with no incremental bleeding when added to standard of care in the treatment of patients with acute coronary syndromes or established vascular disease," added Veltri.

The results were presented today at the American Heart Association Scientific Sessions in Orlando, FL, in a session titled "Thrombin Receptor Antagonist Is a Selective, Potent Inhibitor of PAR-1 Activity With Predictable Pharmacokinetics."

About TRA-PCI

The Phase II TRA-PCI Trial was a multinational, randomized, double-blind, placebo-controlled dose-ranging trial assessing oral loading doses and maintenance doses of TRA. The trial enrolled 1,030 patients randomized to one of three oral loading doses of TRA (10 mg, 20 mg, 40 mg) plus standard of care (clopidogrel + aspirin) or placebo plus standard of care in a 3:1 ratio of active drug to placebo. Patients who received a TRA-loading dose and subsequently underwent PCI (n=573) were randomized to one of three oral daily maintenance doses of TRA (0.5 mg, 1.0 mg, 2.5 mg). Patients who received placebo were randomized to receive standard of care alone. The total duration of treatment was 60 days. Patients were followed for an additional 60 days post-treatment.

A secondary endpoint in a sub-study within the primary evaluable patient cohort was inhibition of platelet aggregation (IPA) induced by appropriate agonists relative to baseline.

TRA-PCI results were first presented at a late-breaking clinical trial session at the March 2007 Scientific Sessions of the American College of Cardiology/i2 Summit
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Novel Technology Breaks Through Cancer Pain
2. Iomai Trial Shows 100 Percent Immune Response in Elderly Subjects Vaccinated With Novel Travelers Diarrhea Patch Vaccine
3. Pharmacopeia Assists the World Health Organization in the Discovery of Novel Therapeutics for the Treatment of Malaria
4. Quark Pharmaceuticals Files Patent Application Covering Novel Chemical Modifications to its RNAi Molecules
5. Ardea Biosciences, Inc. Announces Completion of Phase 1 Clinical Trials of Novel Investigational HIV Drug RDEA806
6. The Lancet Publishes Major Phase 3 Study on Novel Oral Direct Thrombin Inhibitor
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Phase 2 Clinical Studies Initiated for a Novel Therapeutic Candidate Identified Through Pharmacopeia Collaboration
9. Oncology Drugs Development Update - Worldwide Markets and Forecasts of Approved EGFr/HEr2 Inhibitors, Treatment Costs, Pathway Analysis, Current and Expanded Clinical Indications, and Novel Agents in Development
10. ECLIPSE Data on Effects of Otsukas Investigational Novel Treatment, Tolvaptan, on Advanced Heart Failure Patients Hemodynamics and Urine Output Featured in Heart Failure Society of Americas Late Breaking Trials
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/17/2014)... , Sept. 17, 2014  Decision Resources ... (CD/UC) patients eligible for biologic therapy, only ... biologic. Surveyed gastroenterologists cite patients, discomfort with ... low penetration rates, followed by cost-related issues ... patients receiving biologics, Janssen Biotech,s Remicade and ...
(Date:9/17/2014)... SAN JOSE, Calif. , Sept. 17, 2014 ... as a laureate of The Tech Awards 2014, one ... benefit humanity and spark global change. The Tech Awards, a ... by Applied Materials, Inc., selected Gradian as one of two ... - http://photos.prnewswire.com/prnh/20140917/146680 Gradian equips hospitals ...
(Date:9/17/2014)... Texas , Sept. 17, 2014  Lightbeam ... Direct Accountable Care Organization (Physician Direct ACO) to ... their physicians in providing better care while reducing ... Physician Direct Accountable Care Organization ... Network Services (OPNS). The OPNS mission is to ...
Breaking Medicine Technology:The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 2The Majority of Surveyed Gastroenterologists Agree that Biologics Should be Prescribed to More Patients in the Crohn's Disease and Ulcerative Colitis Treatment Paradigm 3Gradian Health Systems Named A 2014 Laureate of The Tech Awards 2Gradian Health Systems Named A 2014 Laureate of The Tech Awards 3Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 2Physician Direct Accountable Care Organization Selects Lightbeam Health to Enable Better Care at a Lower Cost 3
... Oct. 5 Generex Biotechnology Corporation (Nasdaq: ... update in a letter to shareholders from Interim President ... initiatives for growth. The letter to shareholders reads as ... CEO at Generex, the management team has been working ...
... Calif., Oct. 5 Reprints Desk, Inc. today ... Marketing Survey that polled medical marketers, product and ... management professionals, sales management professionals, and executives about ... use of reprints of peer-reviewed journal articles.  Survey ...
Cached Medicine Technology:Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 2Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 3Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 4Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 5Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 6Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 7Generex Biotechnology Provides a Corporate Update to Address Management's Strategic Initiatives for Growth 8Reprints Desk Survey Highlights Medical Marketers' Key Challenges for Adopting and Using Clinical Reprints in Electronic Format 2Reprints Desk Survey Highlights Medical Marketers' Key Challenges for Adopting and Using Clinical Reprints in Electronic Format 3
(Date:9/17/2014)... 18, 2014 US medical facilities are ... medical waste in 2014. Due to public safety concerns, ... along with municipal solid waste. An increasing number of ... waste (RMW). This includes disposable items that may be ... materials. As a result of increased regulation, most small ...
(Date:9/17/2014)... Battle Creek, MI (PRWEB) September 17, 2014 ... Recovery , an open-ended drug and alcohol treatment program ... gives them a solid foundation in recovery they can ... and depression. , “About 20% of Americans who are ... or both,” commented A Forever Recovery’s CEO Per ...
(Date:9/17/2014)... Final Cut Pro X plugin developers have ... Pixel Film Studios. , “ProBlue 5k is a compilation of ... to epic,” said Christina Austin, CEO of Pixel Film Studios. ... a definite game changer.” , ProBlue 5k is the ultimate ... filmmaker ! This footage compilation of over 100 anamorphic flares ...
(Date:9/17/2014)... Functional Fitness Solution , an everyday ... Sipe that is helping middle-aged adults minimize healthcare costs and ... the attention of Shane Michaels, prompting an investigative review. ... or even 70s what would be the one thing that ... they would probably answer that the just want to feel ...
(Date:9/17/2014)... Buffers that guard against damage to the ends of chromosomes ... melanoma the deadliest form of skin cancer according ... The study has uncovered an important new genetic risk factor ... mole count are the strongest indicators of those most at ... more care in the sun, as they burn more easily. ...
Breaking Medicine News(10 mins):Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 2Health News:Medical Waste Disposal Services in the US Industry Market Research Report Now Available from IBISWorld 3Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 2Health News:Latest A Forever Recovery Blog Post Explores the Link Between Addiction and Depression 3Health News:A New Plugin Entitled ProBlue 5k Was Released Today from Pixel Film Studios Exclusively for Final Cut Pro X 2Health News:Functional Fitness Solution: Review Exposes Dr. Dan Ritchie and Dr. Cody Sipe’s Guide to Everyday Fitness for Longevity 2Health News:Chromosome buffers hold key to better melanoma understanding 2
... with Electronic Medical Record Systems enables Medical Offices ... RequirementsPROVO, Utah, March 25 eFileCabinet, Inc. ... electronic document management (EDM) system with certified ... systems which are used by thousands of medical ...
... Assist Processing Plants.SHREVEPORT, La., March 25 Since 2003, ... to be effective on the poultry processing line against ... Salmonella, E. coli , and Listeria . Now ... control Campylobacter by pre-screening birds for their current load ...
... 25 NovaLign(TM) Orthopaedics, Inc., formerly known as OsteoLign, ... Food and Drug Administration to market its Intramedullary Fixation ... the treatment of long bone fractures, including the humerus, ... to enter the intramedullary fracture fixation market, estimated to ...
... LONDON, March 25 The 2008 Frost ... Strategy Leadership Award is presented to Ferring ... Ferring,s initiatives in providing no-needle injection for ... ZOMAJET 2 VISION and ZOMAJET VISION X, ...
... Health Integrated,s Synergy Targeted Population Management(R) program to ... subscribersPORTLAND, Ore. and TAMPA, Fla., March 25 ... and Medicare managed care services for Oregonians, and ... company, are partnering to improve the health and ...
... March 25 /PRNewswire-Asia-FirstCall/ -- China Medical,Technologies, Inc. ... a leading China-based,medical device company that develops, ... announced that the Company received,quality testing certificate ... ,SPR System,) from one of the State ...
Cached Medicine News:Health News:eFileCabinet Helps Medical Offices Realize Full Benefits of Electronic Medical Record Systems 2Health News:SteriFx Inc. Provides 'Solutions' to Combat Campylobacter 2Health News:NovaLign(TM) Orthopaedics, Inc. Announces its First 510(K) Clearance From the FDA for New Intramedullary Fixation System 2Health News:Frost & Sullivan Accolade for Ferring Pharmaceuticals 2Health News:Frost & Sullivan Accolade for Ferring Pharmaceuticals 3Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 2Health News:CareOregon and Health Integrated Partner to Enhance Services for Oregonians with Chronic Illness 3Health News:China Medical Technologies Announces Receipt of SFDA Quality Testing Certificate for its SPR-based Analysis System 2
... Klein Pump provides optimum flow ... infiltration. Operates on any voltage ... with safety Interlock and easy ... Tubing, Double Spike Tubing, Dual ...
... a major advance in the application ... Combined with precision fluid management, controlled ... grooved probe design and patented cannulae, ... designed to minimize trauma to the ...
... The HK Surgical state of ... speed powered suction performance. It can ... or 2 Abbott/Sorenson Canisters, eliminating time ... Aspirator is designed for powerful performance ...
... generation of the ultra-quiet PSI-TEC ... retains all the smooth, reliable,performance ... leading name for,aspiration surgery worldwide. ... for high powered operation, the ...
Medicine Products: